Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells
As effective treatment of glioblastoma is still an unmet need, targeted delivery systems for efficient treatment are of utmost interest. Therefore, in this paper, surface modifications with a small peptide c(RGD) or physiological protein (ApoE3) were investigated. Cellular uptake in murine endotheli...
Saved in:
Main Authors: | Larissa J. Lubitz (Author), Moritz P. Haffner (Author), Harden Rieger (Author), Gero Leneweit (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
by: Afsana Sheikh, et al.
Published: (2022) -
Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
by: Zhu R, et al.
Published: (2017) -
The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells
by: Eirik A. L. Rustad, et al.
Published: (2022) -
How to Achieve High Encapsulation Efficiencies for Macromolecular and Sensitive APIs in Liposomes
by: Kirsten Ullmann, et al.
Published: (2021) -
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
by: Tang Z, et al.
Published: (2019)